Cooley represented Revance, while Morgan Lewis represented Goldman Sachs & Co. LLC, Cowen and Company LLC, and Guggenheim Securities LLC, as joint book-running managers in the...
Revance Therapeutics’ $200 Million Common Stock Offering
uniQure’s Acquisition of Corlieve Therapeutics
McDermott Will & Emery has advised Corlieve Therapeutics, while Morgan Lewis has advised uniQure on the deal. Corlieve Therapeutics completed its sale to uniQure, with its...